OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis
Johannes A. Kroes, Rafael Alfonso‐Cristancho, Aruna T. Bansal, et al.
ERJ Open Research (2023) Vol. 9, Iss. 2, pp. 00745-2022
Open Access | Times Cited: 8
Johannes A. Kroes, Rafael Alfonso‐Cristancho, Aruna T. Bansal, et al.
ERJ Open Research (2023) Vol. 9, Iss. 2, pp. 00745-2022
Open Access | Times Cited: 8
Showing 8 citing articles:
Biologics in severe asthma: a state-of-the-art review
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
Bishal Gyawali, Steve N. Georas, Sandhya Khurana
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240088-240088
Open Access
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis
Donald R. DiBona, Giovanni Paoletti, Palma Carlucci, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
Donald R. DiBona, Giovanni Paoletti, Palma Carlucci, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
Analysis of the economically justifiable price of mepolizumab in adults with asthma in Colombia
Jefferson Antonio Buendía, Diana Guerrero Patiño, José Tomás Lorenzo Sánchez
Journal of Asthma (2025), pp. 1-11
Closed Access
Jefferson Antonio Buendía, Diana Guerrero Patiño, José Tomás Lorenzo Sánchez
Journal of Asthma (2025), pp. 1-11
Closed Access
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial
Ruchong Chen, Liping Wei, Yuanrong Dai, et al.
ERJ Open Research (2024) Vol. 10, Iss. 3, pp. 00750-2023
Open Access | Times Cited: 3
Ruchong Chen, Liping Wei, Yuanrong Dai, et al.
ERJ Open Research (2024) Vol. 10, Iss. 3, pp. 00750-2023
Open Access | Times Cited: 3
Efficient use of mepolizumab in children: An analysis of the economically justifiable price in Colombia
Jefferson Antonio Buendía, Andrés F. Zuluaga
Pediatric Pulmonology (2024)
Closed Access | Times Cited: 2
Jefferson Antonio Buendía, Andrés F. Zuluaga
Pediatric Pulmonology (2024)
Closed Access | Times Cited: 2
Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review
Ibrahim M Dighriri, Anas I Alnughaythir, Amna A Albesisi, et al.
Cureus (2023)
Open Access | Times Cited: 5
Ibrahim M Dighriri, Anas I Alnughaythir, Amna A Albesisi, et al.
Cureus (2023)
Open Access | Times Cited: 5
The Role of ACT Score in Mepolizumab Discontinuation
N. Solanki, B. Beck, Monica Labadia, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
N. Solanki, B. Beck, Monica Labadia, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The role of ACT score in mepolizumab discontinuation
N. Solanki, B. Beck, Monica Labadia, et al.
Journal of Asthma (2023) Vol. 61, Iss. 6, pp. 550-560
Open Access
N. Solanki, B. Beck, Monica Labadia, et al.
Journal of Asthma (2023) Vol. 61, Iss. 6, pp. 550-560
Open Access
